LLY240712C970000
- 0.14
- -0.01-6.67%
Eli Lilly and Co Newsroom
UBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,100
UBS analyst Trung Huynh maintains $Eli Lilly and Co(LLY.US)$ with a buy rating, and adjusts the target price from $910 to $1,100.According to TipRanks data, the analyst has a success rate of 75.5%
Novo's Ozempic Linked to Improved Brain Health: Study
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
On Friday, the European Medicines Agency (EMA) warned patients using weight-loss drugs, such as Novo Nordisk A/S's (NYSE:NVO) Wegovy, to inform their doctors before general anesthesia or deep
Express News | UBS Raises Eli Lilly's Stock PT to $1100 From $910; Shares Last up 1.1%
UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating
Eli Lilly (LLY) has an average rating of outperform and price targets ranging from $540 to $1,083, according to analysts by Capital IQ.Price: 938.50, Change: +4.36, Percent Change: +0.47
The EU accuses Eli Lilly and Co (LLY.US) and Novo Nordisk A/S (NVO.US) of having risks of post-anesthetic pulmonary inhalation in weight-loss and blood-sugar-lowering drugs.
European health departments warn that there may be a risk of anesthesia complications for patients who are taking glucose-lowering and weight-loss medications before surgery.
Express News | Eli Lilly and Co : UBS Raises Target Price to $1100 From $910
Express News | EMA's PRAC: Product Information of GLP-1 Ras to Be Updated to Include Warning on Surgery Under Anaesthesia or Deep Sedation
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$197.36 Million in Common Stock
$Eli Lilly and Co(LLY.US)$ 10% Shareholder LILLY ENDOWMENT INC sold 210K shares of common stock on Jul 10, 2024 at an average price of $939.816 for a total value of $197.36 million.Source:
Eli Lilly, Novo Nordisk Shares Dip as Pfizer Ramps Up Diabetes Drug Competition
Shares of $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss drugs, Ozempic and Wegovy, by publicly highlighting the disparity between domestic and international pricing.
Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by Berenberg
Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by
Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000
Berenberg analyst Kerry Holford maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $850 to $1000.
Tesla Is a 'Faith-based Stock' With Fundamentals Not Grounded in the Near-term - DataTrek
Novo (NVO) Gets CRL From FDA for Weekly Basal Insulin Icodec
Lilly, DaVita, Illumina Among Top Healthcare Quant Picks Ahead of Q2 Earnings
Eli Lilly Is Maintained at Overweight by JP Morgan
Eli Lilly Is Maintained at Overweight by JP
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,000 to $1,083
On Jul 11, major Wall Street analysts update their ratings for $Eli Lilly and Co(LLY.US)$, with price targets ranging from $1,000 to $1,083.Morgan Stanley analyst Terence Flynn maintains with a buy
SA Subscribers Pitch Stocks That Could Potentially Replace Tesla in Magnificent 7
A majority of the Seeking Alpha community doesn’t think Tesla (NASDAQ:TSLA) should be dropped from the Magnificent 7, according to the latest SA Sentiment Survey, even though the EV maker is seen as the least attractive stock in the list.